National Health Investors Upgraded to “Neutral” by Hilliard Lyons (NHI)
National Health Investors (NYSE:NHI) was upgraded by equities research analysts at Hilliard Lyons from an “underperform” rating to a “neutral” rating in a research note issued to investors on Tuesday, TheFlyOnTheWall.com reports.
National Health Investors (NYSE:NHI) opened at 60.74 on Tuesday. National Health Investors has a 52 week low of $53.01 and a 52 week high of $64.84. The stock has a 50-day moving average of $62.05 and a 200-day moving average of $61.57. The company has a market cap of $2.008 billion and a P/E ratio of 15.78.
National Health Investors (NYSE:NHI) last posted its quarterly earnings results on Monday, August 4th. The company reported $0.94 EPS for the quarter, missing the Thomson Reuters consensus estimate of $1.05 by $0.11. Analysts expect that National Health Investors will post $4.21 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Monday, November 10th. Stockholders of record on Tuesday, September 30th will be given a dividend of $0.77 per share. This represents a $3.08 dividend on an annualized basis and a yield of 5.08%.
National Health Investors, Inc (NYSE:NHI) is a self-managed real estate investment trust (REIT), which invests in income-producing healthcare properties primarily in the long-term care and senior housing industries.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.